$28.16
-0.34-1.19%
Últ. Act.: Sep 16, 9:30 AM
Caris Life Sciences Inc
CAINASDAQ
Caris Life Sciences Earnings & Forecasts
Caris Life Sciences (CAI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Caris Life Sciences Guidance
Caris Life Sciences (CAI) publicó su última previsión de agosto 5, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $1.03B - $1.04B para el período.
En comparación con la previsión anterior, Caris Life Sciences elevado redujo su previsión de ingresos desde un rango anterior de $1B - $1.02B.
Caris Life Sciences ha emitido 7 actualizaciones de orientación entre el agosto 12, 2025 y el agosto 5, 2026. During this period, the company raised its outlook 4 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.01 | $-0.02 | $0.07 | $-0.11 |
| Actual | $0.00 | $0.00 | $0.28 | $0.08 |
| Surprise | -100.0% | +100.0% | +300.0% | +172.7% |
| Revenue | ||||
| Estimate | $237.0M | $209.5M | $280.9M | $173.7M |
| Actual | $263.7M | $216.2M | $292.9M | $216.8M |
| Surprise | +11.3% | +3.19% | +4.27% | +24.8% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.03 | $0.11 | $0.03 | $0.10 |
| Revenue | ||||
| Consensus | $254.7M | $292.9M | — | — |